A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors

NCT00977795 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI moving to Southern Illinois University to start new protocol

Conditions

Brain Neoplasms

Interventions

DRUG: 5-aminolevulinic acid

Sponsor

Endeavor Health